Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1994-08-11
1997-08-19
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
514 2, 435198, A61K 31765, A61K 3177, A61K 3800
Patent
active
056585608
ABSTRACT:
A method of treatment of toxemia in bacterial infection by administration of a pharmaceutical composition comprising a non-ionic biologically active detergent is provided.
REFERENCES:
patent: H1168 (1993-04-01), McKenna et al.
patent: 3450502 (1969-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3740421 (1973-06-01), Schmolka
patent: 4100271 (1978-07-01), Krezanoski
patent: 4100276 (1978-07-01), von Daehne et al.
patent: 4186253 (1980-01-01), Yokoyama et al.
patent: 4395393 (1983-07-01), Schmolka
patent: 4510132 (1985-04-01), Vaara
patent: 4844894 (1989-07-01), Ribi
patent: 4957910 (1990-09-01), Sutton et al.
patent: 5004757 (1991-04-01), Boucher
patent: 5034383 (1991-07-01), Gaffar et al.
patent: 5071649 (1991-12-01), Hunter
patent: 5080894 (1992-01-01), Hunter et al.
patent: 5089260 (1992-02-01), Hunter et al.
patent: 5114708 (1992-05-01), Hunter et al.
patent: 5152979 (1992-10-01), Hunter
patent: 5182104 (1993-01-01), Marcus et al.
patent: 5183687 (1993-02-01), Hunter
patent: 5190748 (1993-03-01), Bachynsky et al.
patent: 5221669 (1993-06-01), Anand et al.
patent: 5240702 (1993-08-01), Hunter et al.
patent: 5264356 (1993-11-01), Rohrschneider
D. Attwood et al., Surfactant System, Chapman & Hall, (1983).
E.Y. Chi et al., "Freeze-fracture study of mast cell secretion", Proc. Natl. Acad. Sci., vol. 73, No. 8, pp.2823-2827, Aug. 1976.
F.V. Chisari et al., "Physiologic Concentrations of Normal Human Plasma Lipoproteins Inhibit the Immortalization of Peripheral B Lymphocytes by the Epstein-Barr Virus", J. Clin. Invest., vol. 68, pp.329-336, Aug. 1981.
J.A. Cook et al., "Modulation of Macrophage Arachidonic Acid Metabolism: Potential Role in the Susceptibility of Rats to Endotoxic Shock", Circulatory Shock, vol. 9, pp. 605-617, (1982).
E.B. Eichbaum et al., "Chlyomicrons Can Inhibit Endotoxin Activity in Vitro", J. of Surgical Research, vol. 51, pp.413-416, (1991).
K. Emancipator et al., "In Vitro Inactivation of Bacterial Endotoxin by Human Lipoproteins and Apolipoproteins", Infection and Immunity, vol. 60, No. 2, pp.596-601, Feb. 1992.
P.M. Flynn et al., "Polymyxin B Moderates Acidosis and Hypotension in Establish, Experimental Gram-Negative Septicemia", J. of Infectious Diseases, vol. 156, No. 5, pp.706-712, Nov. 1987.
M.F. Geertsma et al., "Ingestion of pulmonary surfactant by human monocytes inhibits their antibacterial functions", Mononuclear Phagocytes, Ch. 40, pp.308-314, (1992).
G. Gomez et al., "Protective Action of Luminal Bile Salts in Necrotizing Acute Pancreatitis in Mice", J. Clin. Invest., vol. 86, pp.323-331, Jul. 1990.
R.L. Goodman et al., "Perfluorocarbon Emulsions in Cancer Therapy: Preliminary Observations on Presently Available Formulations", Int. J. Radiation Oncology Biol. Phys., vol. 10, No. 8, pp. 1421-1424, Aug. 1984.
H.W. Harris et al., "Chylomicrons Alter the Fate of Endotoxin, Decreasing Tumor Necrosis Factor Release and Preventing Death", J. of Clinical Investigation, Inc., vol. 91, pp.1028-1034, Mar. 1993.
H.W. Harris et al., "Human Very Low Density Lipoproteins and Chylomicrons Can Protect against Endotoxin-induced Death in Mice", J. of Clinical Investigation, Inc., vol. 86, pp.696-702, Sep. 1990.
T. Ishikawa et al., "Changes in the concentration of plasma lipoproteins and apoproteins following the administration of Triton WR 1339 to rats", J. of Lipid Research, vol. 20, pp.254-264, (1979).
T. Kobayashi et al., "Vesiculation of Platelet Plasma Membranes Induced by Synthetic Phosphatidylcholines", J. Pharmacobio-Dyn., vol. 9, s-131, (1986).
M. Koike et al., "Electron Microscopic Studies on Mode of Action of Polymyxin", J. of Bacteriology, vol. 97, No. 1, pp.448-452, Jan. 1969.
T.A. Lane et al., "Paralysis of Phagocyte Migration Due to an ARtificial Blood Substitute", Blood, vol. 64, No. 2, pp.400-405, Aug. 1984.
R.C. Lee et al., "Surfactant-induced sealing of electropermeablized skeletal muscle membranes in vivo", Proc. Natl. Acad. Sci., vol. 89, pp.4524-4528, May 1992.
D.F. Nutting et al., "Hypolipidemic Effect of Intravenous Pluronic L-81 in Fasted Rats Treated with Triton WR-1339: Possible Inhibition of Hepatic Lipoprotein Secretion", Horm. metabol. Res., vol. 21, pp.113-115, (1989).
R.T. Proffiti et al., "Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar Vesicles", Science, vol. 220, pp.502-505, Apr. 29, 1983.
V.B. Serikov et al., "Formation of Microvesicles in the Endothelial Cells. Parameters of Microvesicle Evolution", Biol. Membranology, vol. 4, pp. 947-954, (1987).
J. Sernatinger et al., "Neutralization of Mouse Xenotropic Virus by Lipoproteins Involves Binding to the Virions", J. gen. Virol., vol. 69, pp.2657-2661, (1988).
D.C. Stokes et al., "Polymyxin B Prevents Lipopolysaccharide-Induced Release of Tumor Necrosis Factor-.alpha. from Alveolar Macrophages", J. of Infectious Diseases, vol. 160, No. 1, pp.52-57, Jul. 1989.
D.R. Storm et al., "Polymyxin and Related Peptide Antibiotics", Ann. Rev. Biochem., vol. 46, pp.723-763, (1977).
M.J. Thomassen et al., "Synthetic Surfactant (Exosurf) Inhibits Endotoxin-stimulated Cytokine Secretion by Human Alveolar Macrophages", Am. J. Respir. Cell Mol. Biol., vol. 7, pp.257-260, (1992).
J.H. Williams, Jr. et al., "Modulation of Rat Granulocyte Traffic by a Surface Active Agent in Vitro and Bleomycin Injury", Proc. of the Society for Experimental Biology and Medicine, vol. 188, pp.461-470, (1988).
V. Wunderlich et al., "Lytic Action of Neurotropic Drugs on Retroviruses in Vitro", Euro. J. Cancer, vol. 16, pp. 1127-1132, (1980).
C.J. van Oss et al., Phagocytic Engulfment and Cell Adhesiveness, M. Dekker, Inc., NY, (1975).
Endothelial Cell Vesicles, Progress in Applied Microcirculation, vol. 9, Ed. F. Hammersen, S. Karger, Basel, (1985).
Huff Sheela J.
Knode Marian C.
LandOfFree
Method of treating endotoxemia by administering tyloxapol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating endotoxemia by administering tyloxapol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating endotoxemia by administering tyloxapol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102725